Citations

Mayo Clinic

Showing 10 of 108522 citations.

Initial Experience With Inpatient Hospital Care at Home for Urologic Disease
Hanchate, Kunal , Pathak, Ram A. , Thiel, David D. , Pak, Raymond , Maniaci, Michael, Lyon, Timothy D. , Pak, Raymond W. , Lyon, Timothy D , Pak, Ray

Urology Practice | August 28, 2024 | Volume: 11 | Issue: 6 | Pages: 975-981

10.1097/upj.0000000000000647 | PMID 39196663 Get It

Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population
Aung, Nay , Nicholls, Hannah , Petersen, Steffen E. , Elliott, Perry , Lopes, Luís R. , Petersen, Steffen E , Aung, Nay , Lopes, Luis Rocha , Chahal, C. Anwar A. , Khanji, Mohammed Y , Rauseo, Elisa , Chadalavada, Sucharitha , Munroe, Patricia B.

JAMA Cardiology | August 28, 2024 | Volume: 9 | Issue: 11 | Pages: 964

10.1001/jamacardio.2024.2190 | PMID 39196575 Get It

ImportanceThe population prevalence of cardiac transthyretin amyloidosis (ATTR) caused by pathogenic variation in the TTR gene (vATTR) is unknown.ObjectiveTo estimate the population prevalence of disease-causing TTR variants and evaluate associated phenotypes and outcomes.Design, Setting, and ParticipantsThis population-based cohort study analyzed UK Biobank (UKB) participants with whole-exome sequencing, electrocardiogram, and cardiovascular magnetic resonance data. Participants were enrolled from 2006 to 2010, with a median follow-up of 12 (IQR, 11-13) years (cutoff date for the analysis, March 12, 2024). Sixty-two candidate TTR variants were extracted based on rarity (minor allele frequency ≤0.0001) and/or previously described associations with amyloidosis if more frequent.ExposureCarrier status for TTR variants.Main Outcomes and MeasuresAssociations of TTR carrier status with vATTR prevalence and cardiovascular imaging and electrocardiogram traits were explored using descriptive statistics. Associations between TTR carrier status and atrial fibrillation, conduction disease, heart failure, and all-cause mortality were evaluated using adjusted Cox proportional hazards models. Genotypic and diagnostic concordance was examined using International Statistical Classification of Diseases, Tenth Revision codes from the hospital record.ResultsThe overall cohort included 469 789 UKB participants (mean [SD] age, 56.5 [8.1] years; 54.2% female and 45.8% male). A likely pathogenic/pathogenic (LP/P) TTR variant was detected in 473 (0.1%) participants, with Val142Ile being the most prevalent (367 [77.6%]); 91 individuals (0.02%) were carriers of a variant of unknown significance . The overall prevalence of LP/P variants was 0.02% (105 of 444 243) in participants with European ancestry and 4.3% (321 of 7533) in participants with African ancestry. The LP/P variants were associated with higher left ventricular mass indexed to body surface area (β = 4.66; 95% CI, 1.87-7.44), and Val142Ile was associated with a longer PR interval (β = 18.34; 95% CI, 5.41-31.27). The LP/P carrier status was associated with a higher risk of heart failure (hazard ratio [HR], 2.68; 95% CI, 1.75-4.12) and conduction disease (HR, 1.88; 95% CI, 1.25-2.83). Higher all-cause mortality risk was observed for non-Val142Ile LP/P variants (HR, 1.98; 95% CI, 1.06-3.67). Thirteen participants (2.8%) with LP/P variants had diagnostic codes compatible with cardiac or neurologic amyloidosis. Variants of unknown significance were not associated with outcomes.Conclusions and RelevanceThis study found that approximately 1 in 1000 UKB participants were LP/P TTR variant carriers, exceeding previously reported prevalence. The findings emphasize the need for clinical vigilance in identifying individuals at risk of developing vATTR and associated poor outcomes.
Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy
Zanwar, Saurabh , Hegenbart, Ute , Bhutani, Divaya , Gertz, Morie A. , Kumar, Shaji , Patwari, Anannya , Cowan, Andrew J., Chen, GuiZhen, Milani, Paolo , Bodanapu, Geethika , Lentzsch, Suzanne , Chakraborty, Rajshekhar , Hegenbart, Ute , Gertz, Morie A , Dispenzieri, Angela , Kumar, Shaji K , Chen, GuiZhen , Palladini, Giovanni , Sanchorawala, Vaishali , Bodanapu, Geethika , Muchtar, E , Milani, Paolo , Bhutani, Divaya , Chakraborty, Rajshekhar , Dispenzieri, Angela , D’Souza, Anita , Palladini, Giovanni , Schönland, Stefan , Muchtar, Eli

Blood | August 28, 2024 | Volume: 144 | Issue: 25 | Pages: 2613-2624

10.1182/blood.2024025899 | PMID 39197073 Get It

Abstract We performed an international retrospective study on 283 patients with light chain (AL) amyloidosis to investigate the prognostic impact of cytogenetic abnormalities by fluorescence in situ hybridization, when treated with frontline daratumumab–based therapy. The cytogenetic subgroups of interest were t(11;14), gain/amp(1q) (hereafter, +1q), hyperdiploidy, deletion(13q), del(17p), and myeloma high-risk (HR) translocations (t[4;14], t[14;16], or t[14;20]). The end points of interest were rate of hematologic complete response (heme-CR), very good partial response (VGPR) or better, and hematologic event-free survival (heme-EFS). The incidence of abnormalities was as follows: t(11;14), 53.4%; deletion (13q), 28.9%; +1q, 22.3%; hyperdiploidy, 19.4%; HR translocations, 6.6%; and deletion(17p), 4.5%. The heme-CR rate by cytogenetic subgroups were as follows: t(11;14) vs no t(11;14), 45.2% vs 41.8% (P=0.597); del(13q) vs no del(13q), 46.8% vs 42.8% (P=0.594); +1q vs no +1q, 30.2% vs 47.9% (P=0.022); hyperdiploidy vs no hyperdiploidy, 39.5% vs 44.9% (P=0.541); HR translocations vs none, 45.5% vs 43.1% (P=0.877); and del(17p) vs no del(17p), 50.0% vs 42.9% (P=0.658), respectively. Similarly, +1q was the only subgroup with a significantly lower VGPR or better rate (64.2% vs 79.0%; P=0.033). At a median follow-up of 19.8 months, the median heme-EFS was 49.6 months (95% CI, 24.7-not reached [NR]), and the 2-year overall survival (OS) was 80.98% (95% CI, 75.6-85.4). The presence of +1q was significantly associated with worse heme-EFS on multivariate analysis (HR 2.06, 95% CI, 1.14-3.71; P=0.017). Notably, there was no adverse prognostic impact of t(11;14) on heme-EFS or OS. In conclusion, +1q is associated with worse outcome in the daratumumab-era. Clinical trials testing novel frontline immunotherapies should be enriched in +1q to further improve outcomes in this subgroup.
Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses
Arnulf, Bertrand , Patel, Krina K. , Manier, Salomon , Callander, Natalie S. , Vij, Ravi, Bahlis, Nizar J. , Solomon, Scott R. , Abrahamsen, Ingerid Weum , Broijl, Annemiek , Chen, Christine , Delforge, Michel , Benjamin, Reuben , Iida, Shinsuke , Truppel-Hartmann, Anna, Zhong, Xiaobo , Piasecki, Julia , Eliason, Laurie , Dhanda, Devender , Felten, Jasper, Caia, Andrea, Popa-McKiver, Mihaela, Patel, Krina , Manier, Salomon , Callander, Natalie , Costa, Luciano J , Bahlis, Nizar Jacques , Abrahamsen, Ingerid Weum , Jagannath, Sundar , Pabst, Thomas , Iida, Shinsuke , Berdeja, Jesús G , Giralt, Sergio , Rodriguez-Otero, Paula , Ailawadhi, Sikander , Cavo, Michèle , Nooka, Ajay K. , Costa, Luciano J. , Moreau, Philippe , Baz, Rachid , Jagannath, Sundar , Raje, Noopur , Scheid, Christof , Berdeja, Jesús G. , Giralt, Sergio , Chen, Yanping , Wu, Fan , Cook, Mark , Rodríguez‐Otero, Paula

Blood | August 28, 2024 | Volume: 144 | Issue: 23 | Pages: 2389-2401

10.1182/blood.2024024582 | PMID 39197072 Get It

Abstract Outcomes are poor in triple-class–exposed (TCE) relapsed and refractory multiple myeloma (R/RMM). In the phase 3 KarMMa-3 trial, patients with TCE R/RMM and 2 to 4 prior regimens were randomized 2:1 to idecabtagene vicleucel (ide-cel) or standard regimens (SRs). An interim analysis (IA) demonstrated significantly longer median progression-free survival (PFS; primary end point; 13.3 vs 4.4 months; P < .0001) and higher overall response rate (ORR) with ide-cel vs SRs. At final PFS analysis (median follow-up, 30.9 months), ide-cel further improved median PFS vs SRs (13.8 vs 4.4 months; hazard ratio [HR], 0.49; 95% confidence interval [CI], 0.38-0.63). PFS benefit with ide-cel vs SRs was observed regardless of number of prior lines of therapy, with greatest benefit after 2 prior lines (16.2 vs 4.8 months, respectively). ORR benefit was maintained with ide-cel vs SRs (71% vs 42%; complete response, 44% vs 5%). Patient-centric design allowed crossover from SRs (56%) to ide-cel upon progressive disease, confounding overall survival (OS) interpretation. At IA of OS, median was 41.4 (95% CI, 30.9 to not reached [NR]) vs 37.9 (95% CI, 23.4 to NR) months with ide-cel and SRs, respectively (HR, 1.01; 95% CI, 0.73-1.40); median OS in both arms was longer than historical data (9-22 months). Two prespecified analyses adjusting for crossover showed OS favoring ide-cel. This trial highlighted the importance of individualized bridging therapy to ensure adequate disease control during ide-cel manufacturing. Ide-cel improved patient-reported outcomes vs SRs. No new safety signals were reported. These results demonstrate the continued favorable benefit-risk profile of ide-cel in early-line and TCE R/RMM. This trial was registered at www.ClinicalTrials.gov as #NCT03651128.
Association of COVID-19 Vaccination With Risk of Medically Attended Postacute Sequelae of COVID-19 During the Ancestral, Alpha, Delta, and Omicron Variant Eras
Swift, Melanie D. , Breeher, Laura E. , Dierkhising, Ross , Hickman, Joel , Johnson, Matthew G. , Roellinger, Daniel , Virk, Abinash , Roellinger, Daniel L , Swift, Melanie D , Breeher, Laura , Johnson, Matthew G

Open Forum Infectious Diseases | August 28, 2024 | Volume: 11 | Issue: 9 | Pages: No page available

10.1093/ofid/ofae495 | PMID 39290777 Get It

Abstract Background Uncertainty exists regarding the effectiveness of COVID-19 vaccine to prevent postacute sequelae of COVID-19 (PASC) following a breakthrough infection. While most studies based on symptom surveys found an association between preinfection vaccination status and PASC symptoms, studies of medically attended PASC are less common and have reported conflicting findings. Methods In this retrospective cohort of patients with an initial SARS-CoV-2 infection who were continually empaneled for primary care in a large US health system, the electronic health record was queried for preinfection vaccination status, demographics, comorbidity index, and diagnosed conditions. Multivariable logistic regression was used to model the outcome of a medically attended PASC diagnosis within 6 months of SARS-CoV-2 infection. Likelihood ratio tests were used to assess the interaction between vaccination status and prevalent variant at the time of infection and between vaccination status and hospitalization for SARS-CoV-2 infection. Results During the observation period, 6.9% of patients experienced medically attended and diagnosed PASC. A diagnosis of PASC was associated with older age, female sex, hospitalization for the initial infection, and an increased severity-weighted comorbidity index and was inversely associated with infection during the Omicron period. No difference in the development of diagnosed PASC was observed between unvaccinated patients and those vaccinated with either 2 doses of an mRNA vaccine or >2 doses. Conclusions We found no association between vaccination status at the time of infection and development of medically diagnosed PASC. Vaccine remains an important measure to prevent SARS-CoV-2 infection and severity. Further research is needed to identify effective measures to prevent and treat PASC.
Signs, Sources, Coping Strategies, and Suggested Interventions for Burnout Among Preclerkship Students at a U.S. Medical School: A Qualitative Focus Group Study
Melo, Valéria , Saifuddin, Hiba, Peng, Lillian , Marshall, Ariela L. , Marshall, Ariela , Wolanskyj, Alexandra P. , Hunderfund, Andrea N. Leep

Academic Medicine | August 28, 2024 | Volume: 99 | Issue: 9 | Pages: 987-996

10.1097/acm.0000000000005744 | PMID 38648293 Get It

Abstract Purpose Research suggests that burnout can begin early in medical school, yet burnout among preclerkship students remains underexplored. This study aimed to characterize burnout signs, sources, coping strategies, and potential interventions among preclerkship students at one U.S. medical school. Method The authors conducted a qualitative study of preclerkship students at Mayo Clinic Alix School of Medicine (MCASOM) in June 2019. Participants completed 2 Maslach Burnout Inventory (MBI) items (measuring frequency of emotional exhaustion and depersonalization) and 2 free-text questions on burnout before participating in 1 of 3 semistructured focus groups. Focus group questions were derived from a literature review on medical student burnout with input from the MCASOM Student Life and Wellness Committee. Group discussions were recorded, transcribed, coded inductively, and analyzed iteratively (along with free-text comments) using a general inductive approach from a constructivist perspective. Results Eighteen of 111 eligible students (16%) participated, with 5/18 (28%) reporting weekly emotional exhaustion and/or depersonalization on MBI items. Analysis of focus group transcripts showed that most students had experienced burnout symptoms during their first or second year, corresponding with school-related stressors and manifesting in cognitive-emotional, physical, and verbal-behavioral ways. Students identified systemic, institutional, and individual burnout drivers and discussed how these drivers interacted (e.g., high standards of excellence at the system level interacted with anxiety and maladaptive thinking at the individual level, creating pressure to always do more). Students used various coping strategies (e.g., self-care, peer support, reframing, and compartmentalization) but emphasized limitations of these strategies and recommended interventions directed toward systemic and institutional burnout drivers. Conclusions This study offers insights into burnout signs and sources among preclerkship medical students that can inform future large-scale studies. Results suggest that burnout emerges from dynamic interactions among systemic, institutional, and individual factors and may benefit from multipronged interventions.
Host WD repeat-containing protein 5 inhibits protein kinase R-mediated integrated stress response during measles virus infection
BenDavid, Ethan, Zhou, Yuqin , Pfaller, Christian K. , Samuel, Charles E. , Ma, Dzwokai, Pfaller, Christian K , Ma, Dzwokai , Yang, Chuyuan

Journal of Virology | August 28, 2024 | Volume: 98 | Issue: 9 | Pages: No page available

10.1128/jvi.01020-24 | PMID 39194235 Get It

ABSTRACT Some negative-sense RNA viruses, including measles virus (MeV), share the characteristic that during their infection cycle, cytoplasmic inclusion bodies (IBs) are formed where components of the viral replication machinery are concentrated. As a foci of viral replication, how IBs act to enhance the efficiency of infection by affecting virus-host interactions remains an important topic of investigation. We previously established that upon MeV infection, the epigenetic host protein, WD repeat-containing protein 5 (WDR5), translocates to cytoplasmic viral IBs and facilitates MeV replication. We now show that WDR5 is recruited to IBs by forming a complex with IB-associated MeV phosphoprotein via a conserved binding motif located on the surface of WDR5. Furthermore, we provide evidence that WDR5 promotes viral replication by suppressing a major innate immune response pathway, the double-stranded RNA-mediated activation of protein kinase R and integrated stress response. IMPORTANCE MeV is a pathogen that remains a global concern, with an estimated 9 million measles cases and 128,000 measles deaths in 2022 according to the World Health Organization. A large population of the world still has inadequate access to the effective vaccine against the exceptionally transmissible MeV. Measles disease is characterized by a high morbidity in children and in immunocompromised individuals. An important area of research for negative-sense RNA viruses, including MeV, is the characterization of the complex interactome between virus and host occurring at cytoplasmic IBs where viral replication occurs. Despite the progress made in understanding IB structures, little is known regarding the virus-host interactions within IBs and the role of these interactions in promoting viral replication and antagonizing host innate immunity. Herein we provide evidence suggesting a model by which MeV IBs utilize the host protein WDR5 to suppress the protein kinase R-integrated stress response pathway.
Retrospective validation study of a machine learning-based software for empirical and organism-targeted antibiotic therapy selection
Tejeda, Maria Isabel, Fernández, Javier , Valledor, Pablo , Almirall, Cristina, Barberán, José , Romero‐Brufau, Santiago , Romero-Brufau, Santiago

Antimicrobial Agents and Chemotherapy | August 28, 2024 | Volume: 68 | Issue: 10 | Pages: No page available

10.1128/aac.00777-24 | PMID 39194206 Get It

ABSTRACT Errors in antibiotic prescriptions are frequent, often resulting from the inadequate coverage of the infection-causative microorganism. The efficacy of iAST, a machine-learning-based software offering empirical and organism-targeted antibiotic recommendations, was assessed. The study was conducted in a 12-hospital Spanish institution. After model fine-tuning with 27,531 historical antibiograms, 325 consecutive patients with acute infections were selected for retrospective validation. The primary endpoint was comparing each of the top three of iAST’s antibiotic recommendations’ success rates (confirmed by antibiogram results) with the antibiotic prescribed by the physicians. Secondary endpoints included examining the same hypothesis within specific study population subgroups and assessing antibiotic stewardship by comparing the percentage of antibiotics recommended that belonged to different World Health Organization AWaRe groups within each arm of the study. All of iAST first three recommendations were non-inferior to doctor prescription in the primary endpoint analysis population as well as the secondary endpoint. The overall success rate of doctors’ empirical treatment was 68.93%, while that of the first three iAST options was 91.06% ( P < 0.001), 90.63% ( P < 0.001), and 91.06% ( P < 001), respectively. For organism-targeted therapy, the doctor’s overall success rate was 84.16%, and that of the first three ranked iAST options was 97.83% ( P < 0.001), 94.09% ( P < 0.001), and 91.30% ( P < 0.001), respectively. In empirical therapy, compared to physician prescriptions, iAST demonstrated a greater propensity to recommend access antibiotics, fewer watch antibiotics, and higher reserve antibiotics. In organism-targeted therapy, iAST advised a higher utilization of access antibiotics. The present study demonstrates iAST accuracy in predicting antibiotic susceptibility, showcasing its potential to promote effective antibiotic stewardship. CLINICAL TRIALS This study is registered with ClinicalTrials.gov as NCT06174519 .
mDia2 is an important mediator of MRTF-A-dependent regulation of breast cancer cell migration
Eder, Ian , Yu, Virginia, Antonello, Jacob , Chen, Fangyuan , Joy, Marion , Boone, David N. , Roy, Partha , Chen, Fangyuan , Roy, Partha , Chen, Fangyuan, Gau, David M. , Chawla, Pooja A. , Lucas, Peter C. , Lee, Adrian V.

Molecular Biology of the Cell | August 28, 2024 | Volume: 35 | Issue: 10 | Pages: No page available

10.1091/mbc.e24-01-0008 | PMID 39196658 Get It

Dysregulated actin cytoskeleton gives rise to aberrant cell motility and metastatic spread of tumor cells. This study evaluates the effect of overexpression of wild-type versus functional mutants of MRTF-A on migration and invasion of breast cancer (BC) cells. Our studies indicate that SRF's interaction is critical for MRTF-A-induced promotion of both two-dimensional and three-dimensional cell migration, while the SAP-domain function is important selectively for three-dimensional cell migration. Increased MRTF-A activity is associated with more effective membrane protrusion, a phenotype that is attributed predominantly to SRF's interaction with MRTF. We demonstrate formin-family protein mDia2 as an important mediator of MRTF-stimulated actin polymerization at the leading edge and cell migration. Multiplexed quantitative immunohistochemistry and transcriptome analyses of clinical BC specimens further demonstrate a positive correlation between nuclear localization of MRTF with malignant traits of cancer cells and enrichment of MRTF–SRF gene signature in pair-matched distant metastases versus primary tumors. In conclusion, this study establishes a novel mechanism of MRTF-dependent regulation of cell migration and provides evidence for the association between MRTF activity and increased malignancy in human BC, justifying future development of specific small molecule inhibitors of the MRTF-SRF transcriptional complex as potential therapeutic agents in BC.
Augmented Reality‐Guided Frozen Section Analysis: Bringing the Pathologist From the Laboratory to the Operating Room
Aweeda, Marina , Huang, Liyu , Perez, Alexander , Ely, Kim, Mehrad, Mitra , Lewis, James S. , Topf, Michael C. , Topf, Michael C

OTO Open | August 28, 2024 | Volume: 8 | Issue: 3 | Pages: No page available

10.1002/oto2.70002 | PMID 39206428 Get It

AbstractDue to the anatomic complexity of the head and neck and variable proximity between laboratory and operating room (OR), effective communication during frozen section analysis (FSA) between surgeons and pathologists is challenging. This proof‐of‐concept study investigates an augmented reality (AR) protocol that allows pathologists to virtually join the OR from the laboratory. Head and neck cancer specimens were scanned ex vivo using a 3‐dimensional scanner and uploaded into an AR platform. Eight head and neck specimens were discussed by surgeons and pathologists in an AR environment. AR‐guided intraoperative consultation was used for specimen orientation and discussion of FSA margin sampling sites. One patient had positive initial margins on FSA and was re‐resected to negative final margins. AR‐guided FSA is possible and allows pathologists to join the operating from any location for intraoperative discussion.